Financhill
Back

Eagle Pharmaceuticals 10K Form

Sell
14

EGRX
Eagle Pharmaceuticals

Last Price:
0.90
Seasonality Move:
-5.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive EGRX News And Ratings

See the #1 stock for the next 7 days that we like better than EGRX

EGRX Financial Statistics

Sales & Book Value

Annual Sales: $316.61M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $19.25
Price / Book: 0

Profitability

EPS (TTM): 0.91000
Net Income (TTM): $11.95M
Gross Margin: $221.67M
Return on Equity: 0%
Return on Assets: 0%

Eagle Pharmaceuticals Earnings Forecast

Key Eagle Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 11 years for EGRX is 70.01%.
  • The Selling, General & Administrative Expenses for EGRX have been equal to 33.68% of Gross Profit Margin.
  • The Research & Development expenses have been 10.77% of Revenue.
  • The Interest Expense is 11.35% of Operating Income.
  • The Net Earning history of EGRX is 11.26% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 4 years.

Eagle Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: EGRX
CUSIP: 269796
Website: eagleus.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

EGRX Technical Analysis vs Fundamental Analysis

Sell
14
Eagle Pharmaceuticals (EGRX) is a Sell

Is Eagle Pharmaceuticals a Buy or a Sell?